Harvard BioscienceFRA:HBI0 48 Median PS Value is €15.00 as of Jun. 26, 2026, which is 100% below its 10-year median of 1.00. GuruFocus rates FRA:HBI0 with a GF Score™ of 48/100 and a GF Value™ of €13.30. The stock has 6 warning signs investors should review. Among 338 Medical Devices & Instruments companies, Harvard Bioscience ranks better than 89.64% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Harvard Bioscience's Median PS Value or its related term are showing as below:
FRA:HBI0'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.19 Med: 1 Max: 2.68
Current: 0.27
During the past 13 years, the highest Price to Median PS Value of Harvard Bioscience was 2.68. The lowest was 0.19. And the median was 1.00.
FRA:HBI0's Price-to-Median-PS-Value is ranked better than 89.64% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs FRA:HBI0: 0.27
Harvard Bioscience (FRA:HBI0) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Harvard Bioscience's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
4.08
/
15.00
=
0.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Bioscience Median PS Value Related Terms
Harvard Bioscience Median PS Value Historical Data
* Premium members only.
The historical data trend for Harvard Bioscience's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HBI0 vs FEMY, RVP, MLSS: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, Harvard Bioscience's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harvard Bioscience Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Harvard Bioscience's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Harvard Bioscience's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.9092.
Harvard Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.498.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Bioscience (FRA:HBI0) has a Median PS Value of €15.00 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Harvard Bioscience and its competitors. This is 1400% above median its historical median of 1.00. Over the past decade, Harvard Bioscience's Median PS Value has ranged from 0.19 to 2.68. According to the industry distribution chart, Harvard Bioscience ranks #35 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 10.4%.
Is Harvard Bioscience's Median PS Value too high?
Harvard Bioscience's current Median PS Value of €15.00 is 1400% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 2.68. Based on the distribution chart, Harvard Bioscience ranks #35 out of 338 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Harvard Bioscience has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Harvard Bioscience's Median PS Value compare to FEMY and RVP?
According to the Medical Devices & Instruments industry distribution chart, Harvard Bioscience ranks #35 out of 338 companies for Median PS Value. This places Harvard Bioscience in the top 10% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Harvard Bioscience's own Median PS Value has ranged from 0.19 to 2.68 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Harvard Bioscience and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Bioscience's current Median PS Value is €15.00, which is 1400% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Bioscience stock overvalued right now?
Harvard Bioscience (FRA:HBI0) has a current Median PS Value of €15.00. The stock's GF Value™ is €13.30, compared to a current price of €4.08 — trading 69.3% below its estimated fair value. The current Median PS Value is €15.00, which is 1400% above median its 10-year median of 1.00. Harvard Bioscience's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Harvard Bioscience (FRA:HBI0), the current Median PS Value is €15.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harvard Bioscience (FRA:HBI0) Overvalued in 2026?
Based on GuruFocus' analysis, Harvard Bioscience stock appears to be undervalued.
The current stock price of €4.08 is trading 69.3% below its estimated GF Value™ of €13.30.
Key valuation signals for FRA:HBI0:
Median PS Value: €15.00 (1400% above median its 10-year median of 1.00)
GF Value™: €13.30 vs. price of €4.08 (69.3% below fair value)
No single metric tells the full story. See the FRA:HBI0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
48GF Score
Get the complete analysis for FRA:HBI0
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HBI0 has been successfully added to your 
